Cortisol Burden Mitigation is the clinical and physiological process of reducing the overall cumulative exposure of tissues to excessively high or poorly regulated levels of the glucocorticoid hormone, cortisol. This involves interventions aimed at normalizing the diurnal rhythm and decreasing the hyper-secretion of cortisol resulting from chronic stress or HPA axis dysregulation. Successful mitigation protects metabolic, immune, and cognitive health from the catabolic effects of sustained cortisol excess.
Origin
The concept stems from the clinical recognition of allostatic load, where repeated or chronic stress leads to cumulative physiological wear and tear, largely mediated by glucocorticoid exposure. The phrase “cortisol burden” quantifies the damaging impact of prolonged hypercortisolemia. Mitigation represents the therapeutic strategy to lessen this endocrine load on the body’s systems.
Mechanism
Effective mitigation strategies target multiple points in the stress response pathway, including reducing afferent stress signals to the hypothalamus and enhancing negative feedback sensitivity at the pituitary and hypothalamus. Certain compounds can modulate the activity of the 11β-Hydroxysteroid Dehydrogenase enzymes, controlling local cortisol concentrations within tissues like the brain and adipose tissue. Ultimately, the goal is to restore the integrity of the HPA axis’s regulatory feedback loop, thereby decreasing the total daily cortisol output.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.